Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of neoadjuvant preoperative short-course radiation followed by envafolimab plus CAPEOX in microsatellite stable (MSS)/mismatch repair proficient (pMMR) locally advanced rectal cancer.
Authors
Sheng Dai
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China;
Sheng Dai , Fei Wang , Yanbin Shen , Liming Shi , Lingna Xu , Chuanxi Lai , Feixiang Zhang , Kangke Zhang , Dengyong Xu , Lina Shan , Gaoyang Cao , Da Wang , Weifeng Lao , Xiaonan Sun , Xuefeng Huang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT05216653
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 134)
DOI
10.1200/JCO.2023.41.4_suppl.134
Abstract #
134
Poster Bd #
G12
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
International real-world study of TOTAL neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC).
First Author: Alessandro Audisio
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in JAPAN: ENSEMBLE-1 study.
First Author: Yoshinori Kagawa
Poster
2019 Gastrointestinal Cancers Symposium
The efficacy of neoadjuvant treatment in locally advanced rectal cancer with dMMR.
First Author: Yanhong Deng
Poster
2011 ASCO Annual Meeting
Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer.
First Author: S. J. Wong